{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:07:34Z","timestamp":1793995654019,"version":"4.8.0"},"reference-count":82,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["31M290"],"award-info":[{"award-number":["31M290"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a common neurodegenerative disorder, characterized by selective degeneration of dopaminergic nigrostriatal neurons. Most of the existing pharmacological approaches in PD consider replenishing striatal dopamine. It has been reported that activation of the cholinergic system has neuroprotective effects on dopaminergic neurons, and human \u03b17-nicotinic acetylcholine receptor (\u03b17-nAChR) stimulation may offer a potential therapeutic approach in PD. Our recent in-vitro studies demonstrated that curcumin causes significant potentiation of the function of \u03b17-nAChRs expressed in Xenopus oocytes. In this study, we conducted in vivo experiments to assess the role of the \u03b17-nAChR on the protective effects of curcumin in an animal model of PD. Intra-striatal injection of 6-hydroxydopmine (6-OHDA) was used to induce Parkinsonism in rats. Our results demonstrated that intragastric curcumin treatment (200 mg\/kg) significantly improved the abnormal motor behavior and offered neuroprotection against the reduction of dopaminergic neurons, as determined by tyrosine hydroxylase (TH) immunoreactivity in the substantia nigra and caudoputamen. The intraperitoneal administration of the \u03b17-nAChR-selective antagonist methyllycaconitine (1 \u00b5g\/kg) reversed the neuroprotective effects of curcumin in terms of both animal behavior and TH immunoreactivity. In conclusion, this study demonstrates that curcumin has a neuroprotective effect in a 6-hydroxydopmine (6-OHDA) rat model of PD via an \u03b17-nAChR-mediated mechanism.<\/jats:p>","DOI":"10.3390\/ijms21197329","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T08:35:57Z","timestamp":1601886957000},"page":"7329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson\u2019s Disease is Mediated by \u03b17-Nicotinic Receptors"],"prefix":"10.3390","volume":"21","author":[{"given":"Eslam","family":"El Nebrisi","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Dubai Medical College, Dubai Medical University, Dubai 20170, UAE"},{"name":"Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain PO BOX 17666, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayate","family":"Javed","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain PO BOX 17666, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-2966","authenticated-orcid":false,"given":"Shreesh K","family":"Ojha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain PO BOX 17666, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Oz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain PO BOX 17666, UAE"},{"name":"Department of Pharmacology and Therapeutics, College of Pharmacy, Kuwait University, Kuwait 24923, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Shehab","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain PO BOX 17666, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments","volume":"6","author":"Maiti","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"Breteler","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: Sporadic Parkinson\u2019s disease: Development and distribution of \u03b1-synuclein pathology","volume":"42","author":"Braak","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s Disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_6","first-page":"266","article-title":"The Parkinson Disease Mitochondrial Hypothesis","volume":"22","author":"Iborra","year":"2015","journal-title":"Neuroscience"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/mds.23767","article-title":"Parkinson\u2019s disease, proteins, and prions: Milestones","volume":"26","author":"Olanow","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","article-title":"Parkin ubiquitinates the \u03b1-synuclein\u2013interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease","volume":"7","author":"Chung","year":"2001","journal-title":"Nat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"II3","DOI":"10.1007\/PL00007758","article-title":"Pathoanatomy of Parkinson\u2019s disease","volume":"247","author":"Braak","year":"2000","journal-title":"J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S1353-8020(11)70038-4","article-title":"Striatal plasticity in Parkinson\u2019s disease and L-DOPA induced dyskinesia","volume":"18","author":"Iravani","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuropharm.2013.06.005","article-title":"TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque","volume":"73","author":"Johnston","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0006-8993(02)03571-0","article-title":"Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson\u2019s disease","volume":"956","author":"Guan","year":"2002","journal-title":"Brain Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mds.25028","article-title":"Nicotine as a potential neuroprotective agent for Parkinson\u2019s disease","volume":"27","author":"Quik","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1046\/j.1460-9568.2003.02564.x","article-title":"Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors","volume":"17","author":"Marubio","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bcp.2013.08.001","article-title":"Neuronal nicotinic receptors as analgesic targets: It\u2019s a winding road","volume":"86","author":"Umana","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1007\/s10803-016-2890-6","article-title":"Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder","volume":"46","author":"Olincy","year":"2016","journal-title":"J. Autism Dev. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-5793(96)01215-X","article-title":"An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics","volume":"398","author":"Weiland","year":"1996","journal-title":"FEBS Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.euroneuro.2016.07.004","article-title":"Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study","volume":"26","author":"Marcus","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(00)00066-2","article-title":"Neuronal nicotinic receptors, important new players in brain function","volume":"393","author":"Clementi","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_22","first-page":"29","article-title":"Neuronal Nicotinic Acetylcholine Receptors: Common Molecular Substrates of Nicotine and Alcohol Dependence","volume":"4","author":"Hendrickson","year":"2013","journal-title":"Front. Psychol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuropharm.2014.11.003","article-title":"Diversity of native nicotinic receptor subtypes in mammalian brain","volume":"96","author":"Zoli","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(92)90179-B","article-title":"Pharmacological properties of the homomeric \u03b17 receptor","volume":"146","author":"Bertrand","year":"1992","journal-title":"Neurosci. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0896-6273(90)90344-F","article-title":"A neuronal nicotinic acetylcholine receptor subunit (\u03b17) is developmentally regulated and forms a homo-oligomeric channel blocked by \u03b1\u03b1-BTX","volume":"5","author":"Couturier","year":"1990","journal-title":"Neuron"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0165-0270(95)00032-P","article-title":"A sensitive technique for the detection of the \u03b17 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain","volume":"61","author":"Turek","year":"1995","journal-title":"J. Neurosci. Methods"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: From basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Maiti, P., Maiti, P., and Manna, J. (2015). Dietary Curcumin: A Potent Natural polyphenol for Neurodegenerative Diseases Therapy. MOJ Anat. Physiol., 1.","DOI":"10.15406\/mojap.2015.01.00026"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-1922-x","article-title":"Neuroprotective properties of curcumin in toxin-base animal models of Parkinson\u2019s disease: A systematic experiment literatures review","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1124\/jpet.117.245068","article-title":"Curcumin Acts as a Positive Allosteric Modulator of \u03b17-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain","volume":"365","author":"Bagdas","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuint.2017.12.010","article-title":"Curcumin potentiates the function of human \u03b17-nicotinic acetylcholine receptors expressed in SH-EP1 cells","volume":"114","author":"Yang","year":"2018","journal-title":"Neurochem. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0006-8993(91)90170-Z","article-title":"Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections","volume":"554","author":"Schwarting","year":"1991","journal-title":"Brain Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10787-016-0297-9","article-title":"Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats","volume":"25","author":"Singh","year":"2016","journal-title":"Inflammopharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neulet.2010.12.014","article-title":"Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis","volume":"489","author":"Jaisin","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","article-title":"Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease","volume":"39","author":"Zbarsky","year":"2005","journal-title":"Free. Radic. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12264-012-1238-2","article-title":"Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson\u2019s disease","volume":"28","author":"Du","year":"2012","journal-title":"Neurosci. Bull."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1159\/000484302","article-title":"Protective Effect of Curcumin Against Oxidative Stress-Induced Injury in Rats with Parkinson\u2019s Disease Through the Wnt\/ \u03b2-Catenin Signaling Pathway","volume":"43","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.prp.2015.11.012","article-title":"Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats","volume":"212","author":"Song","year":"2016","journal-title":"Pathol. Res. Pr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10787-007-1614-0","article-title":"Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson\u2019s disease induced by MPTP neurodegeneration in mice","volume":"16","author":"Rajeswari","year":"2008","journal-title":"Inflammopharmacology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1213\/ANE.0000000000000902","article-title":"The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of \u03b17 Nicotinic Acetylcholine Receptors in Mice","volume":"121","author":"Bagdas","year":"2015","journal-title":"Anesthesia Analg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2012.08.022","article-title":"Effects of \u03b17 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models","volume":"65","author":"Freitas","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1476-5381.2012.02003.x","article-title":"The \u03b17 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat","volume":"167","author":"Munro","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neuron.2006.05.007","article-title":"Hierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors","volume":"50","author":"Evrard","year":"2006","journal-title":"Neuron"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuint.2017.12.012","article-title":"Nicotinic acetylcholine receptor (nAChR) mediated dopamine release in larval Drosophila melanogaster","volume":"114","author":"Pyakurel","year":"2018","journal-title":"Neurochem. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2006.04078.x","article-title":"Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates","volume":"98","author":"Quik","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.expneurol.2014.09.015","article-title":"The \u03b17 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions","volume":"263","author":"Bordia","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3458.2004.tb00010.x","article-title":"TC-1734: An Orally Active Neuronal Nicotinic Acetylcholine Receptor Modulator with Antidepressant, Neuroprotective and Long-Lasting Cognitive Effects","volume":"10","author":"Gatto","year":"2006","journal-title":"CNS Drug Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/1568007023339166","article-title":"The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration","volume":"1","author":"Fromm","year":"2002","journal-title":"Curr. Drug Target CNS Neurol. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2741\/2695","article-title":"Neuroprotection via nAChRs: The role of nAChRs in neurodegenerative disorders such as Alzheimer\u2019s and Parkinson\u2019s disease","volume":"13","author":"Picciotto","year":"2008","journal-title":"Front. Biosci"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.apsb.2017.09.001","article-title":"The current agonists and positive allosteric modulators of \u03b17 nAChR for CNS indications in clinical trials","volume":"7","author":"Yang","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1523\/JNEUROSCI.07-12-03915.1987","article-title":"The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems","volume":"7","author":"Gerfen","year":"1987","journal-title":"J. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tins.2004.06.006","article-title":"Putting a spin on the dorsal\u2013ventral divide of the striatum","volume":"27","author":"Voorn","year":"2004","journal-title":"Trends Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0079-6123(00)25005-X","article-title":"Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system","volume":"125","author":"Descarries","year":"2000","journal-title":"Prog. Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0006-8993(81)90843-X","article-title":"Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum","volume":"225","author":"Pickel","year":"1981","journal-title":"Brain Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/neu.10150","article-title":"Cholinergic interneuron characteristics and nicotinic properties in the striatum","volume":"53","author":"Zhou","year":"2002","journal-title":"J. Neurobiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nn769","article-title":"Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum","volume":"4","author":"Zhou","year":"2001","journal-title":"Nat. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/mol.116.104240","article-title":"Understanding the Bases of Function and Modulation of \u03b17 Nicotinic Receptors: Implications for Drug Discovery","volume":"90","author":"Corradi","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autneu.2013.12.007","article-title":"The cholinergic anti-inflammatory pathway: A critical review","volume":"182","author":"Martelli","year":"2014","journal-title":"Auton. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.05.002","article-title":"Cholinergic modulation of the immune system presents new approaches for treating inflammation","volume":"179","author":"Hoover","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Lao, C.D., Ruffin, I.M.T., Normolle, D.P., Heath, D.D., I Murray, S., Bailey, J.M., E Boggs, M., Crowell, J., Rock, C.L., and E Brenner, D. (2006). Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med., 6.","DOI":"10.1186\/1472-6882-6-10"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.fct.2011.05.001","article-title":"Safety assessment of a solid lipid curcumin particle preparation: Acute and subchronic toxicity studies","volume":"49","author":"Dadhaniya","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"ref_63","first-page":"535","article-title":"Chemopreventive efficacy and pharmacokinetics of curcumin in the min\/+ mouse, a model of familial adenomatous polyposis","volume":"11","author":"Perkins","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/942981","article-title":"Neurodegenerative Shielding by Curcumin and Its Derivatives on Brain Lesions Induced by 6-OHDA Model of Parkinson\u2019s Disease in Albino Wistar Rats","volume":"2012","author":"Agrawal","year":"2012","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.brainres.2010.10.023","article-title":"Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: Behavioral, neurochemical and immunohistochemical studies","volume":"1368","author":"Khuwaja","year":"2011","journal-title":"Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.prp.2014.02.005","article-title":"Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson\u2019s disease rat","volume":"210","author":"Yang","year":"2014","journal-title":"Pathol. Res. Pr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00221-006-0439-1","article-title":"Experimental manipulations of the subthalamic nucleus fail to suppress tonic seizures in the electroshock model of epilepsy","volume":"173","author":"Shehab","year":"2006","journal-title":"Exp. Brain Res."},{"key":"ref_68","unstructured":"Paxinos, G., and Watson, C. (2005). The Rat Brain in Stereotaxic Coordinates, Elsevier Academic Press."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.11.026","article-title":"Developing a preclinical model of Parkinson\u2019s disease: A study of behaviour in rats with graded 6-OHDA lesions","volume":"169","author":"Truong","year":"2006","journal-title":"Behav. Brain Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2016.10.070","article-title":"The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA","volume":"340","author":"Konieczny","year":"2017","journal-title":"Neuroscience"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainres.2004.05.003","article-title":"Quantitative analyses of GFR\u03b1-1 and GFR\u03b1-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat","volume":"1016","author":"Kozlowski","year":"2004","journal-title":"Brain Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neures.2007.12.006","article-title":"Specific induction of PAG608 in cranial and spinal motor neurons of L-DOPA-treated parkinsonian rats","volume":"60","author":"Shimizu","year":"2008","journal-title":"Neurosci. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroscience.2014.04.016","article-title":"High-frequency electrical stimulation of the subthalamic nucleus excites target structures in a model using c-fos immunohistochemistry","volume":"270","author":"Shehab","year":"2014","journal-title":"Neuroscience"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.nbd.2011.06.002","article-title":"Effective inhibition of substantia nigra by deep brain stimulation fails to suppress tonic epileptic seizures","volume":"43","author":"Shehab","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-8993(92)90345-A","article-title":"Glutamate-immunoreactive synapses on retrogradely-labelled sympathetic preganglionic neurons in rat thoracic spinal cord","volume":"581","author":"Phend","year":"1992","journal-title":"Brain Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","article-title":"Comparison of the behavioural and histological characteristics of the 6-OHDA and \u03b1-synuclein rat models of Parkinson\u2019s disease","volume":"235","author":"Decressac","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_78","first-page":"321","article-title":"Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson\u2019s Disease","volume":"10","author":"Javed","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/mt.2015.232","article-title":"Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach for Parkinson\u2019s Disease and Other Brain Disorders","volume":"24","author":"Javed","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2014.04.011","article-title":"Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"257","author":"Shin","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: Issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:16:23Z","timestamp":1760177783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":82,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["ijms21197329"],"URL":"https:\/\/doi.org\/10.3390\/ijms21197329","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,3]]}}}